- Marketwired•10 months ago
Cortex Pharmaceuticals, Inc. is providing investors and shareholders with a 2015 year-end update and a summary overview of the Company's clinical trial plans for 2016.
- Marketwired•last year
Cortex Pharmaceuticals, Inc. , a leader in developing drugs for respiratory disorders, particularly obstructive and central sleep apneas and drug-induced respiratory depression, announces that it will ...
- Marketwired•last yearCortex Pharmaceuticals, Inc. Announces Appointment of James S. J. Manuso, Ph.D., as President and Chief Executive Officer, Vice Chairman of the Board of Directors
Cortex Pharmaceuticals, Inc. , a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today announced the appointment of James S. J. Manuso, Ph.D., ...
** SEE<RSPI> (CORX)
Other OTC - Other OTC Delayed Price. Currency in USD
At close: 3:33 PM EST
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|